Drug Interactions

Active Resources: 17

Webinar Recordings

Harm Reduction Initiative in KY: Lessons Learned

11/6/2019
Drug Interactions Involving Medications for HIV, HCV and Mental Health Conditions

1/12/2017

Image Library

AIDSinfo Illustrated Glossary

2/20/2019 (reviewed: 2/20/2019)

Clinical Reference Tools

HIV and HCV Drug Interactions: Quick Guides for Clinicians

2/1/2019
Drug Interactions with Oral Contraceptives and HIV Medications 2015

5/3/2017 (reviewed: 5/3/2017)

Antiretroviral Guidelines

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

10/25/2018

Coinfection Guidelines (Hep, TB, STIs)

Archive Resources: 1

Pocket Guides

Recreational Drugs and HIV Antivirals: A Guide to Interactions for Clinicians

2/1/2014

Articles: 5

Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)

April 11, 2018
Jennifer Cocohoba, PharmD, UCSF Center for HIV Information, AETC National Coordinating Resource Center
Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain...
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference

August 31, 2017
Laura Cheever, MD, ScM , HRSA HIV/AIDS Bureau
Highlights from Laura W. Cheever, MD, ScM, HRSA HIV/AIDS Bureau Associate Administrator and Conference Co-Chair
The field of HIV/AIDS care and treatment continues to evolve rapidly. Groundbreaking developments in HIV research are regularly presented at international meetings and...
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy

April 12, 2016
Jennifer Cocohoba, PharmD, UCSF Center for HIV Information, AETC National Coordinating Resource Center
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted...
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV

October 1, 2015
Jennifer Cocohoba, PharmD, UCSF Center for HIV Information, AETC National Coordinating Resource Center
The prevailing opinion among experts regarding the optimal CD4 T-cell count at which to start patients on antiretroviral therapy (ART) has shifted several times during the evolution of HIV treatment. These shifts reflect attempts to strike a balance between preventing HIV-associated illness and...
Pitavastatin and Darunavir/Ritonavir

October 5, 2012
Ian R. McNicholl, PharmD, BCPS (AQ-Infectious Diseases), AAHIVE
Coauthor: Susa Coffey, MD; Medical Editor, AETC National Resource Center
Treatment of dyslipidemia is often complicated by drug interactions between statins and antiretrovirals. Pitavastatin is one of the newer statins approved and is one of the few that is not...